Systemic Amyloidosis: Is It ATTR or AL? - 20/06/23
Doi : 10.1016/j.amjmed.2023.03.009
Joel Singh, MD a, Jennifer Oliver-Krasinski, MD b, James Tauras, MD c, Benjamin T. Galen, MD d, ⁎ 
a Department of Internal Medicine, Residency Training Program
b Department of Pathology
c Department of Internal Medicine, Division of Cardiovascular Medicine
d Department of Internal Medicine, Division of Hospital Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY
⁎Requests for reprints should be addressed to Benjamin T. Galen, MD, Weiler Division, Department of Medicine, Montefiore Medical Center, Suite 2-76, 1825 Eastchester Road, Bronx, NY 10461.Weiler Division, Department of MedicineMontefiore Medical CenterSuite 2-76, 1825 Eastchester RoadBronxNY10461
Thomas J. Marrie, MD, Section Editor
Le texte complet de cet article est disponible en PDF.Plan
| Funding: The authors have no financial disclosures to report. |
|
| Conflicts of Interest: The authors have no conflicts of interest to disclose. |
|
| Authorship: All authors contributed to the preparation of this manuscript. The patient provided written consent for presentation of his case. |
© 2023
Elsevier Inc. Tous droits réservés.
Vol 136 - N° 7
P. 652-654 - juillet 2023 Retour au numéro
Article précédent
- Lumbar Disc Herniation: Diagnosis and Management
- Andrew S. Zhang, Andrew Xu, Kashif Ansari, Kyle Hardacker, George Anderson, Daniel Alsoof, Alan H. Daniels
- Extensive Palpable Purpura Preceding Renal Dysfunction in Immunoglobulin A Vasculitis Due to Coronavirus-19 Infection
- Carolyn G. Ahlers, Bangchen Wang, David N. Howell, Vinay Choksi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?